16:43 EDT GRI Bio files to sell 4.13M shares of common stock for holders
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on GRI:
- GRI Bio (NASDAQ: GRI) to Participate in the Virtual Investor Ask the CEO Conference
- GRI Bio Announces Publication of Comprehensive Invariant NKT (iNKT) Cell Review in Frontiers in Immunology Demonstrating a Key Role of Type 1 iNKT Cells in Modulating Various Fibrotic Conditions
- GRI Bio announces article on iNKT cell review in Frontiers in Immunology
- GRI Bio to Present at the H.C. Wainwright 25th Annual Global Investment Conference
- GRI Bio Enters into Asset Purchase Agreement with Aardvark Therapeutics, Inc. for the Sale of Legacy Asset, ADAIR